EGFR-IN-31
EGFR-IN-31 is a potent inhibitor of EGFR. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-31 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185298A1, compound 2).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2701563-03-1
- Formel: C32H36FN7O2
- Molecular Weight:569.67
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle EGFR Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Chemical Information
-
CAS. Nr. 2701563-03-1
-
Molecular Weight 569.67
-
Formel C32H36FN7O2
-
SMILES
O=C(NC1=CC(NC2=NC(NC3=CC=C(C)C=C3)=C(C4=CC=C(C=C4)F)C=N2)=C(C=C1N(CCN(C)C)C)OC)C=C
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)